| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.COPH.2012.05.004 |
| P698 | PubMed publication ID | 22726555 |
| P50 | author | Christopher A Alabi | Q88641167 |
| P2093 | author name string | Daniel Anderson | |
| Arturo Vegas | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanocarrier | Q17153796 |
| P304 | page(s) | 427-433 | |
| P577 | publication date | 2012-06-21 | |
| P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
| P1476 | title | Attacking the genome: emerging siRNA nanocarriers from concept to clinic | |
| P478 | volume | 12 |
| Q41786279 | Advances in Lipid Nanoparticles for siRNA Delivery |
| Q38971775 | Biomaterials in siRNA Delivery: A Comprehensive Review |
| Q48282746 | Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy. |
| Q38221915 | Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge. |
| Q38154803 | Delivery materials for siRNA therapeutics |
| Q92255077 | Efficient Delivery of dsRNA and DNA in Cultured Silkworm Cells for Gene Function Analysis Using PAMAM Dendrimers System |
| Q47155492 | Efficient in vitro delivery of Noggin siRNA enhances osteoblastogenesis |
| Q92341122 | Efficient nanocarriers of siRNA therapeutics for cancer treatment |
| Q38205584 | Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatments. |
| Q37710952 | In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. |
| Q33581506 | Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides |
| Q37088608 | Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery |
| Q38106032 | Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges. |
| Q50199832 | Nanoparticle-Delivered IRF5 siRNA Facilitates M1 to M2 Transition, Reduces Demyelination and Neurofilament Loss, and Promotes Functional Recovery After Spinal Cord Injury in Mice. |
| Q30601810 | Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair |
| Q38168518 | Non-Viral Delivery and Therapeutic Application of Small Interfering RNAs |
| Q38826539 | Non-coding RNAs: Therapeutic Strategies and Delivery Systems |
| Q34429032 | Non-viral vectors for gene-based therapy |
| Q38305253 | Star-shaped tetraspermine enhances cellular uptake and cytotoxicity of T-oligo in prostate cancer cells |
| Q39227810 | The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market |
| Q36421258 | Utilisation of nanoparticle technology in cancer chemoresistance. |
Search more.